Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
new york
4
×
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
abbvie
acorda therapeutics
akcea therapeutics
allergan
alzheimer's
ampyra
anylam pharmaceuticals
apokyn
apomorphine
arkansas
bern
bristol-myers squibb
cardiomyopathy
clinical data
dalfampridine
dementia
disease
drugs
duopa
food and drug administration
genfit
gilead sciences
houston
inbrija
inotersen
intercept pharmaceuticals
ipad
japan
ldl-c
What
approved
4
×
drug
disease
patients
fda
new
acorda
admi
ago
akcea
alnylam
altoida
amyloidosis
attr
augmented
available
battle
chief
company
cope
data
debilitating
developing
diseases
episodes
fatty
food
founder
friday
genetic
gets
help
horizon
identifying
illness
intercept
ioannis
known
late
liver
Language
Current search:
approved
×
" new york "
×
@techcrunch.com
5 years ago
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms